Smith & Nephew (SNNUF) Cash from Investing Activities (QoQ) (2010 - 2014)
Smith & Nephew (SNNUF) Cash from Investing Activities (QoQ) (2010 - 2014) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Smith & Nephew | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | -1,698.97% |
| Mar 31, 2014 | -76.36% |
| Mar 31, 2013 | -27.59% |
| Mar 31, 2012 | -610.74% |
| Dec 31, 2011 | -80.60% |
| Sep 30, 2011 | 32.32% |
| Jun 30, 2011 | -47.76% |
| Mar 31, 2011 | 9.46% |
| Dec 31, 2010 | -10.45% |
| Sep 30, 2010 | -157.69% |
| Jun 30, 2010 | 75.70% |
| Mar 31, 2010 | 24.65% |